Who Buys Letrozole from India — 508 Importers Behind a $32.1M Market

The importation of Letrozole from India involves various buyer segments, each with distinct purchasing behaviors:

• Government Procurement Agencies: The Government Pharmaceutical Organization (Thailand) exemplifies this segment, accounting for $14.91 million in imports. Such agencies typically engage in large-scale, tender-based procurement to supply public healthcare facilities, ensuring consistent availability of essential medicines.

• Pharmaceutical Distributors: Entities like EVERSANA Life Sciences Services, LLC (United States, $2.44 million combined) and Yusen Logistics Benelux Belgium ($0.61 million) fall into this category. They purchase in bulk to distribute to various healthcare providers, pharmacies, and hospitals, often maintaining regular order patterns to meet ongoing demand.

• Contract Manufacturers: Companies such as Accord UK (United Kingdom, $1.45 million) and Aurobindo Pharma USA, Inc. ($0.42 million) import Letrozole for formulation and packaging under their brand names. Their procurement is aligned with production schedules and market demand forecasts.

• Retail Chains and Hospital Groups: Organizations like Apotex Australia ($0.48 million) and Sun Pharma Philippines Inc. ($0.32 million) represent this segment. They procure Letrozole to stock their pharmacies and healthcare facilities, ensuring availability for patients, with purchasing patterns influenced by prescription trends and inventory levels.

• Re-exporters: Companies such as Pharmaland (1982) Co. Ltd (Thailand, $0.29 million) may import Letrozole for redistribution to neighboring markets, leveraging regional demand and trade agreements. Their buying behavior is often opportunistic, based on market dynamics and profit margins.

Understanding these segments aids in tailoring market strategies to meet the specific needs and behaviors of each buyer type.

Import regulations for Letrozole vary across the top importing countries:

• Thailand:
• Regulatory Authority: Thai Food and Drug Administration (FDA).
• Import Registration Process: Requires a valid import license and product registration with the Thai FDA. The importer must have a physical presence in Thailand.
• Estimated Timeline: Approximately 6-12 months, depending on dossier completeness and regulatory reviews.
• Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are typically subject to a 0% import duty, but VAT may apply.

• United States:
• Regulatory Authority: U.S. Food and Drug Administration (FDA).
• Import Registration Process: Requires FDA approval of the drug application (ANDA or NDA) and compliance with Current Good Manufacturing Practices (cGMP).
• Estimated Timeline: Varies; ANDA approvals can take 10 months or more.
• Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are generally duty-free.

• United Kingdom:
• Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
• Import Registration Process: Requires a Marketing Authorization (MA) from the MHRA and adherence to UK Good Distribution Practice (GDP).
• Estimated Timeline: Approximately 12 months, subject to assessment procedures.
• Import Tariff/Duty: Post-Brexit, import duties may apply; typically, pharmaceuticals have a 0% duty rate, but VAT is applicable.

• Philippines:
• Regulatory Authority: Food and Drug Administration Philippines.
• Import Registration Process: Requires a Certificate of Product Registration (CPR) and compliance with local labeling requirements.
• Estimated Timeline: 6-12 months, depending on the evaluation process.
• Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are generally subject to a 0% import duty, but VAT applies.

• Australia:
• Regulatory Authority: Therapeutic Goods Administration (TGA).
• Import Registration Process: Requires inclusion in the Australian Register of Therapeutic Goods (ARTG) and compliance with TGA standards.
• Estimated Timeline: Approximately 12 months, depending on the application category.
• Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are typically duty-free, but Goods and Services Tax (GST) applies.

Compliance with these regulations is essential for market entry and sustained operations in these countries.

The demand for Letrozole is primarily driven by its role in treating hormone receptor-positive breast cancer, a prevalent condition in many countries. The inclusion of Letrozole in the WHO Model List of Essential Medicines underscores its importance in global health. (cdn.who.int)

Government healthcare programs and the expansion of universal health coverage have increased access to essential medicines, including Letrozole. Tender-based purchasing mechanisms are commonly employed to procure such medicines, ensuring cost-effectiveness and consistent supply. The presence of 508 buyers across 117 countries indicates a broad and sustained demand, presenting significant market opportunities for suppliers.

The importation of Letrozole from India involves various buyer segments, each with distinct purchasing behaviors:

• Government Procurement Agencies: The Government Pharmaceutical Organization (Thailand) exemplifies this segment, accounting for $14.91 million in imports. Such agencies typically engage in large-scale, tender-based procurement to supply public healthcare facilities, ensuring consistent availability of essential medicines.

• Pharmaceutical Distributors: Entities like EVERSANA Life Sciences Services, LLC (United States, $2.44 million combined) and Yusen Logistics Benelux Belgium ($0.61 million) fall into this category. They purchase in bulk to distribute to various healthcare providers, pharmacies, and hospitals, often maintaining regular order patterns to meet ongoing demand.

• Contract Manufacturers: Companies such as Accord UK (United Kingdom, $1.45 million) and Aurobindo Pharma USA, Inc. ($0.42 million) import Letrozole for formulation and packaging under their brand names. Their procurement is aligned with production schedules and market demand forecasts.

• Retail Chains and Hospital Groups: Organizations like Apotex Australia ($0.48 million) and Sun Pharma Philippines Inc. ($0.32 million) represent this segment. They procure Letrozole to stock their pharmacies and healthcare facilities, ensuring availability for patients, with purchasing patterns influenced by prescription trends and inventory levels.

• Re-exporters: Companies such as Pharmaland (1982) Co. Ltd (Thailand, $0.29 million) may import Letrozole for redistribution to neighboring markets, leveraging regional demand and trade agreements. Their buying behavior is often opportunistic, based on market dynamics and profit margins.

Understanding these segments aids in tailoring market strategies to meet the specific needs and behaviors of each buyer type.

Import regulations for Letrozole vary across the top importing countries:

• Thailand:
• Regulatory Authority: Thai Food and Drug Administration (FDA).
• Import Registration Process: Requires a valid import license and product registration with the Thai FDA. The importer must have a physical presence in Thailand.
• Estimated Timeline: Approximately 6-12 months, depending on dossier completeness and regulatory reviews.
• Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are typically subject to a 0% import duty, but VAT may apply.

• United States:
• Regulatory Authority: U.S. Food and Drug Administration (FDA).
• Import Registration Process: Requires FDA approval of the drug application (ANDA or NDA) and compliance with Current Good Manufacturing Practices (cGMP).
• Estimated Timeline: Varies; ANDA approvals can take 10 months or more.
• Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are generally duty-free.

• United Kingdom:
• Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
• Import Registration Process: Requires a Marketing Authorization (MA) from the MHRA and adherence to UK Good Distribution Practice (GDP).
• Estimated Timeline: Approximately 12 months, subject to assessment procedures.
• Import Tariff/Duty: Post-Brexit, import duties may apply; typically, pharmaceuticals have a 0% duty rate, but VAT is applicable.

• Philippines:
• Regulatory Authority: Food and Drug Administration Philippines.
• Import Registration Process: Requires a Certificate of Product Registration (CPR) and compliance with local labeling requirements.
• Estimated Timeline: 6-12 months, depending on the evaluation process.
• Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are generally subject to a 0% import duty, but VAT applies.

• Australia:
• Regulatory Authority: Therapeutic Goods Administration (TGA).
• Import Registration Process: Requires inclusion in the Australian Register of Therapeutic Goods (ARTG) and compliance with TGA standards.
• Estimated Timeline: Approximately 12 months, depending on the application category.
• Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are typically duty-free, but Goods and Services Tax (GST) applies.

Compliance with these regulations is essential for market entry and sustained operations in these countries.

The demand for Letrozole is primarily driven by its role in treating hormone receptor-positive breast cancer, a prevalent condition in many countries. The inclusion of Letrozole in the WHO Model List of Essential Medicines underscores its importance in global health. (cdn.who.int)

Government healthcare programs and the expansion of universal health coverage have increased access to essential medicines, including Letrozole. Tender-based purchasing mechanisms are commonly employed to procure such medicines, ensuring cost-effectiveness and consistent supply. The presence of 508 buyers across 117 countries indicates a broad and sustained demand, presenting significant market opportunities for suppliers.